Condition 1: Deep vein thromboembolism. Condition 2: Malignant neoplasm of lower respiratory tract. Acute embolism and thrombosis of deep veins of lower extremity Malignant neoplasm of lower respiratory tract, part unspecified
Conditions
Interventions
Intervention 1: Control group: There are 35 patients. In this group, subcutaneous injections are given daily for 3 months to prevent DVT Enoxaparin at a dose of 40 mg. Intervention 2: Intervention gro
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cancer patients referred to Kosar Hospital in Semnan (all metastatic patients with either progressive symptoms or in the phase of slowing down the disease)
Exclusion criteria
Exclusion criteria: High blood pressure (180/120 or more) Moderate or severe hepatic insufficiency Glomerular filtration rate (GFR) less than 30ml / min Severe bleeding (requiring hospitalization) Blood and hemorrhagic diseases include: hemophilia, Von Willebrand factor deficiency, problems of factors 2, 5, 7,10 and 12, types of Anemia, blood transfusions, Thrombocytopenia, Bernard-Soulier syndrome, Glanzmann, plaque pool storage deficiency syndrome, Vitamin K deficiency, Dysfibrinogenemia, Immune thrombocytopenia purpura (ITP), Acute lymphoblastic leukemia (ALL), Bleeding diathesis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thromboembolism. Timepoint: After seeing the initial symptoms taught to the patient himself. Method of measurement: Doppler ultrasound.;Bleeding. Timepoint: After seeing the initial symptoms taught to the patient himself. Method of measurement: PTT? Activated PTT? BT. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPouya Youseflee
Semnan University of Medical Sciences
Outcome results
None listed